Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is widely used to treat
malignant hematological neoplasms and non-malignant hematological disorders …

Umbilical cord blood transplantation (UCBT) has been performed in the clinic for over 30
years. The biological and immunological characteristics of umbilical cord blood (UCB) have …

Background Both extracellular vesicles from mesenchymal stromal cell-derived human
umbilical cords (hUC-EVs) and arsenic trioxides (ATOs) have been demonstrated to treat …

Viral infections are important causes of morbidity and mortality after allogeneic stem cell
hematopoietic transplantation (allo-HSCT). Although most viral infections present with …

Hematopoietic stem cell transplantation activity in Europe : Current Opinion in Hematology
Hematopoietic stem cell transplantation activity in Europe : Current Opinion in Hematology Log …

Background Intensified conditioning regimens (increasing the intensity of standard
myeloablative conditioning) for hematological malignancies in allogeneic hematopoietic …

Purpose: Although myeloablative HLA haploidentical hematopoietic stem cell
transplantation (haplo-HSCT) following pretransplant anti-thymocyte globulin (ATG) and …

Human leukocyte antigen (HLA)-matched donors for hematopoietic stem cell transplantation
(HSCT) have long been scarce in China. Haploidentical (haplo) donors are available for the …

Human pluripotent stem cells (hPSCs) have been suggested as a potential source for the
production of blood cells for clinical application. In two decades, almost all types of blood …

A key issue in the haploiedntical hematopoietic stem cell transplantation (haplo-HSCT)
setting is the search for the best donor, because donor selection can significantly impact the …